Q8I480 AF NFT

RING finger protein PFE0100w

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeif4357gyoggtfrsbop5m25ywjxqtblrji7ym6qiwxhw7isyzwkhge/metadata.json
IPFS of structure file: 
bafybeib6nwqpom7mv75cyq665uimyilu2wqnbg3s2siggkm77kj2nm76ue/AF-Q8I480-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x71112d4fF7ebb3b617963c05f052289e073082FD
First NFT owner address (bech32): 
genesis1wygj6nlhawemv9uk8szlq53gncrnpqha56an79
Current NFT ID #541711 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
541711
Accession (UniProt):
Q8I480
Name::
RING finger protein PFE0100w
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8I480 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8I480|ZNRF2_PLAF7 RING finger protein PFE0100w OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PFE0100w PE=1 SV=1 MFNFRNLPLFDKDNSKDTDDIKNFINSYEGIYFSSSNKFINVFLDKILIIDPSSLNVITINTDLYVVDFLFNEKNKNLIVLGKGKNSLICSVYNIRECNFTLLKKIQLSKNINNIKKTLIAKCNEYIITLENKKITFYFLNKDYSINQSELIEDGKELIENIYLSKNHILLVIKNSYVYIYQLDIKNSHISYTLIDSFNLNLSYLRESINNKKKHINKINDVSNNDPKKDNNEKNTSSNNITHNNYNDISNNNNNNNNINGVKDHINNNTLENNDEPILSIYNEDLNVLYICQNMYNVLFVLNLNNLSFEFILLENKIINLFSCKFYLILLKEVNKKFFLHIYIIYEDMKLLVSTLLLNEPISNVIFFNNLFCLLIEEEISKPEIKVDKFYFYEQLKLKLHSKLDGDALKILKRDHVTNNINICKQEEKKYKLKNEQKDVEIYNKNNTVDSTNNTIYNSEVNHYKYITNDFFLNEDVNTDIKKELYNLNHTKDNINHDTLKKQTNQNDITMSLSKDEKNNDTNKFFNENMFTLNKFFKNCRNQIKIILKERNINEIINMFKKKKLYQWLIKYANLNKNYQIININFIHKIYADFLFEKEQYENAIYEYIQTINYLETSYVIHKYLNLDLYEYLTIYLEKLHVYHHFNDEHTMMLLSCYKKQCKKKKMISFIKKNKDKINLNKTYKFLLNAGYYNIVLNLSKKYKDHFTYVSILIEKYENYEKSLKYIFKLDVENICILLFKYGYKFIKYYPQLTIYLLKKIIKKYNINLTIFIPLFLDNIDFLFMFIVKFLDKNVNINKINHIQEKQKHHYSNMYHDSDELNSVTKQKNKINSFLLYEKDNNQNHNGIPSDSHNLSDDNNSQESTTAVNLINKTNLQLDIFNGEYDYILFVTVIQILLQKYKKSMQEENQTNNQSSKQTNNQSSKQTNKQSINQSNNQSINQTNNQSIKQTNIQTNKQKGNSTTNKIINKDETNEQNNILTFNIDKLIQNNKDKNINFLSVLLLSIYNYNKGLIYTSTQMNKYDISLLFSIHKFINNTKGKINKINMDEHKPNEQTMQINSSYKILNRNFQKVIYNICINHLKLNGSLSYNYIFYYLSMLNDEKYLIKFIKKIRQDMNLSIFNLIQILKKYNKSYSCIQNMVVAYMNDMNKNINDKCIEIEKDKKELEKIKKKQLKKKYNFYLIDNAYCSICKEILSVPMIHFLCKHSYHSYCLKDNNVCILCHNKDKEKKLLKEKAINSIQNFDEFFKYLQGSTDKFSYISNYLSYGITPK